Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of DirectorsMore News
Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical StudyMore News
Assertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCORead More
